Clinical trials
Completed Frontotemporal Dementia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
92 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 2 |
| 2013 | 7 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 5 |
| 2017 | 8 |
| 2018 | 9 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 8 |
| 2022 | 3 |
| 2023 | 10 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 92 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 5 |
| University of California, San Francisco | 5 |
| University of Pennsylvania | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Columbia University | 3 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 3 |
| Mayo Clinic | 3 |
| Alector Inc. | 2 |
| Avid Radiopharmaceuticals | 2 |
| Axon Neuroscience SE | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Frontotemporal Dementia | 92 |
| Alzheimer Disease | 43 |
| Dementia | 29 |
| Frontotemporal Lobar Degeneration | 15 |
| Dementia, Vascular | 14 |
| Lewy Body Disease | 14 |
| Aphasia, Primary Progressive | 11 |
| Cognitive Dysfunction | 10 |
| Pick Disease of the Brain | 9 |
| Amyotrophic Lateral Sclerosis | 7 |
Trials
Showing 76 to 92 of 92. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.